ResearcherKobe University HospitalNo recent work listed

Yutaka Fujiwara

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6981-0800; OpenAlex author ID A5061760818. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper

Papers 2

Metabolomics evaluation of serum markers for cachexia and their intra-day variation in patients with advanced pancreatic cancer. Co-author DOI 10.1371/journal.pone.0113259 ↗
A novel serum metabolomics-based diagnostic approach to pancreatic cancer. Co-author DOI 10.1158/1055-9965.epi-12-1033 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hironobu Minami · 2 shared papers, 2013–2014 · strength 0.07
- Paper Metabolomics evaluation of serum markers for cachexia and their intra-day variation in patients with advanced pancreati… DOI 10.1371/journal.pone.0113259 ↗
- Paper A novel serum metabolomics-based diagnostic approach to pancreatic cancer. DOI 10.1158/1055-9965.epi-12-1033 ↗
Takeshi Azuma · 2 shared papers, 2013–2014 · strength 0.07
- Paper Metabolomics evaluation of serum markers for cachexia and their intra-day variation in patients with advanced pancreati… DOI 10.1371/journal.pone.0113259 ↗
- Paper A novel serum metabolomics-based diagnostic approach to pancreatic cancer. DOI 10.1158/1055-9965.epi-12-1033 ↗
Takashi Kobayashi · 2 shared papers, 2013–2014 · strength 0.07
- Paper Metabolomics evaluation of serum markers for cachexia and their intra-day variation in patients with advanced pancreati… DOI 10.1371/journal.pone.0113259 ↗
- Paper A novel serum metabolomics-based diagnostic approach to pancreatic cancer. DOI 10.1158/1055-9965.epi-12-1033 ↗
Masaru Yoshida · 2 shared papers, 2013–2014 · strength 0.07
- Paper Metabolomics evaluation of serum markers for cachexia and their intra-day variation in patients with advanced pancreati… DOI 10.1371/journal.pone.0113259 ↗
- Paper A novel serum metabolomics-based diagnostic approach to pancreatic cancer. DOI 10.1158/1055-9965.epi-12-1033 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.